Veritas In Silico Inc. (TYO:130A)
Japan · Delayed Price · Currency is JPY 303.00
-4.00 (-1.30%)
Oct 27, 2026, 10:02 AM JST
Veritas In Silico Market Cap
Veritas In Silico has a market cap or net worth of 1.97 billion as of October 26, 2026. It is the 40,053rd most valuable company in the world and the 3,703rd biggest in Japan. Its market cap has decreased by 46.84% in one year.
Market Cap
1.97B
Enterprise Value
535.29M
Revenue
84.42M
Global Rank
Country Rank
#3,703 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since February 8, 2024, Veritas In Silico's market cap has decreased from 15.76B to 1.97B, a decrease of -87.53%. That is a compound annual growth rate of -53.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 1.97B | -36.88% |
| Dec 30, 2025 | 3.11B | -45.58% |
| Dec 30, 2024 | 5.72B | -63.69% |
| Feb 8, 2024 | 15.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kohjin Bio | 3.92B |
| Chordia Therapeutics | 3.86B |
| Noile-Immune Biotech | 3.82B |
| Ribomic | 3.73B |
| D. Western Therapeutics Institute | 3.68B |
| Transgenic Group | 3.45B |
| Human Metabolome Technologies | 3.28B |
| Modalis Therapeutics | 2.98B |